SMBG device market forecast points to steady growth through 2030

The self-monitoring blood glucose devices market is projected to rise from $16.19 billion in 2025 to $24.17 billion by 2030, driven by diabetes growth, home healthcare adoption and connected health tools. North America led the market in 2025, while Europe is expected to grow fastest over the forecast period.

Why it matters: - Demand for self-monitoring blood glucose devices is rising as more people need regular glucose checks to manage diabetes. - The market is also benefiting from home healthcare, telehealth and connected health systems that make monitoring easier outside traditional clinical settings. - The expanding pool of people at risk for type 2 diabetes points to continued demand for glucose meters and related products.

What happened: - The Business Research Company released its Self-Monitoring Blood Glucose (SMBG) Devices Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report projects the SMBG devices market to grow from $16.19 billion in 2025 to $17.56 billion in 2026. - The report forecasts the market will reach $24.17 billion by 2030, with an 8.3% CAGR over the period. - The market is described as expanding on the back of wider self-monitoring awareness, cost-effective glucose meters and improved diabetes management protocols.

The details: - SMBG devices are portable tools that measure blood glucose from a small blood sample, usually taken by pricking a finger. - The devices help patients track glucose levels in real time and adjust diet, medication or physical activity as needed. - International medical guidelines endorse SMBG as a key method for helping patients manage diabetes and avoid complications. - The report identifies connected health technologies, telehealth-based diabetes care and preventive health strategies as major drivers of future growth. - In June 2024, the UK National Health Service said 549,000 more people in England were identified as at risk for type 2 diabetes in 2023 than in the prior year. - The NHS said 3,615,330 people were registered with general practitioners as having pre-diabetes in 2023, up nearly 20% from 3,065,825 in 2022. - The report says North America held the largest share of the SMBG devices market in 2025. - The report expects Europe to be the fastest-growing regional market. - The regional coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, hotspot infographics, and updated graphics and tables.

Between the lines: - The growth forecast suggests SMBG is shifting from a basic monitoring category to part of a broader digital diabetes-care ecosystem. - The regional outlook points to mature demand in North America and faster adoption potential in Europe as healthcare systems invest in chronic disease management. - The NHS figures highlight how pre-diabetes screening can expand the customer base for monitoring devices before full diabetes diagnosis.

What's next: - The report points to continued expansion through 2030 as connected monitoring and telehealth become more embedded in routine diabetes care. - The Business Research Company is offering a free sample and full report for readers seeking deeper market data and segment analysis. - More information - The full report